The safety and efficacy of a new anticoagulation strategy using selective in-circuit blood cooling during haemofiltrationan experimental study

Nephrology Dialysis Transplantation

Volumn 26, Issue 5, 2011, Pages 1622-1627

  Krouzecky, Ales ^a   Chvojka, Jiri ^a   Sykora, Roman ^a   Radej, Jaroslav ^a   Karvunidis, Thomas ^a   Novak, Ivan ^a   Hanzlikova, Jana ^b   Bultasova, Lenka ^b   Ruzicka, Jiri ^b   Petrankova, Zuzana ^b   Matejovic, Martin ^a  

^a Teaching Hospital   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

anticoagulation; extracorporeal blood circuit; renal replacement therapy; selective blood cooling

Indexed keywords

CALCIUM ION; CHLORIDE ION; CREATINE KINASE; HEMOGLOBIN; HEPARIN; INTERLEUKIN 10; INTERLEUKIN 6; LACTIC ACID; MALONALDEHYDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; POTASSIUM ION; SODIUM ION; THROMBIN ANTITHROMBIN COMPLEX; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANTICOAGULATION; ARTERIAL GAS; ARTICLE; BLAST TRANSFORMATION; CONTINUOUS HEMOFILTRATION; CONTINUOUS INFUSION; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; COOLING; CORE TEMPERATURE; DEVICE; ERYTHROCYTE COUNT; EXPERIMENTAL PIG; EXPERIMENTAL STUDY; EXTRACORPOREAL CIRCUIT PATENCY; EXTRACORPOREAL CIRCULATION; HEMODYNAMICS; HEMOGLOBIN BLOOD LEVEL; HEMOSTASIS; HEPARINIZATION; INFLAMMATION; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; MEMBRANE FILTER; NONHUMAN; OXIDATIVE STRESS; PARTIAL THROMBOPLASTIN TIME; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RESPIRATORY BURST; SAFETY; SELECTIVE IN CIRCUIT BLOOD COOLING; T LYMPHOCYTE; TEMPERATURE; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; TRANSMEMBRANOUS PRESSURE; TREATMENT OUTCOME; VENOUS PRESSURE; WARMING;

ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; DISEASE MODELS, ANIMAL; EXTRACORPOREAL CIRCULATION; HEMOFILTRATION; HEPARIN; INFLAMMATION; INTERLEUKIN-6; OXIDATIVE STRESS; RENAL INSUFFICIENCY; SWINE;

EID: 79955633763     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq622     Document Type: Article

References (23)

1. Wolberg AS, Meng ZH, Monroe DM 3rd et al. A systematic evalu-ation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma 2004; 56: 1221-1228 (Pubitemid 38901832)
2. Kermode JC, Zheng Q, Milner EP. Marked temperature dependence of the platelet calcium signal induced by human von Willebrand factor Blood 1999; 94: 199-207 (Pubitemid 29300150)
3. Maggiore Q, Enia G, Catalano C et al. Effect of blood cooling on cuprophan-induced anaphylatoxin generation. Kidney Int 1987; 32: 908-911 (Pubitemid 18015524)
4. Otte KE, Jensen PB, Svendsen P et al. Heparin-free hypothermal hemodialysis at 20 degrees C improves biocompatibility. Blood Purif 1997; 15: 200-207 (Pubitemid 27348345)
5. Krouzecky A, Chvojka J, Sykora R et al. Regional cooling of the extracorporeal blood circuit: a novel anticoagulation approach for renal replacement therapy? Intensive Care Med 2009; 35: 364-370
6. Ball J. Recently publishedpapers: changing bandwagons, innovations and questioning dogma. Crit Care 2009; 13: 157
7. Lee JBL, Forni LG. Recently published papers: acute kidney injury-diagnosis and treatment. Crit Care 2009; 37: 553-560
8. Jentzsch A, Bachmann H, Fürst P et al. Improved analysis of malon-dialdehyde in human body fluids. Free Radic Biol Med 1996; 20: 251-256 (Pubitemid 26021882)
9. Watts DD, Trask A, Soeken K et al. Hypothermic coagulopathy in trauma: effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity. JTrauma 1998; 44: 846-854 (Pubitemid 28233032)
10. Valeri CR, Feingold H, Cassidy G et al. Hypothermia-induced rever-sible platelet dysfunction. Ann Surg 1987; 205: 175-181
11. Andrews RK, Berndt MC. Platelet physiology: in cold blood. Curr Biol 2003; 13: R282-R284 (Pubitemid 36391928)
12. Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med 2009; 37: S186-S202
13. Opatrny K Jr. Clinical importance of biocompatibility andits effect on haemodialysis treatment. Nephrol Dial Transplant 2003; 18: 41-44
14. Vienken J, Bowry S. Quo vadis dialysis membrane? Artif Organs 2002; 26: 152-159 (Pubitemid 34225212)
15. Velik-Salchner C, Schnürer C, Fries D et al. Normal values for thrombelastography (ROTEM) and selected coagulation parameters in porcine blood. Thromb Res 2006; 117: 597-602 (Pubitemid 43326147)
16. Reverdiau-Moalic P, Watier H, Vallée I et al. Comparative study of porcine and human blood coagulation systems: possible relevance in xenotransplantation. Transplant Proc 1996; 28: 643-644 (Pubitemid 26138347)
17. Kaspareit J, Messow C, Edel J. Blood coagulation studies in guinea-pigs (Cavia porcellus). Lab Anim 1988; 22: 206-211
18. Baldwin I, Bellomo R, Koch B. Blood flow reductions during con-tinuous renal replacement therapy and circuit life. Intensive Care Med 2004; 30: 2074-2079 (Pubitemid 40022324)
19. Joannidis M, Oudemans-van Straaten HM. Clinical review: patency of the circuit in continuous renal replacement therapy. Crit Care 2007; 11: 218
20. Schetz MR. Coagulation disorders in acute renal failure. Kidney Int Suppl 1998; 66: S96-S101
21. Oudemans-van Straaten HM, Wester JP, de Pont AC et al. Anticoa-gulation strategies in continuous renal replacement therapy: can the choice be evidence based? Intensive Care Med 2006; 32: 188-202 (Pubitemid 43251138)
22. Rajgopal R, Bear M, Butcher MK et al. The effects of heparin and low molecular weight heparins on bone. Thromb Res 2008; 122: 293-298 (Pubitemid 351888881)
23. Apsner R, Hörl WH, Sunder-Plassmann G Dalteparin-induced alo-pecia in hemodialysis patients: reversal by regional citrate anticoagu-lation. Blood 2001; 97: 2914-2915